Key Takeaways
- Rule-of-thumb percentages (60–85% of collections) ignore overhead and can miss the mark by seven figures. A diligence-grade valuation starts with normalized EBITDA.
- Three recognized methods, collections-percentage, EBITDA-multiple, and asset-based, can be run and cross-checked to produce a defensible fair-market-value range.
- Normalization of owner compensation and discretionary expenses can be the single largest swing factor. Every add-back must be documented to survive a buyer’s quality-of-earnings review.
- DSO buyers price on normalized EBITDA (often 5–11×) while private buyers price on collections. The same practice can yield materially different outcomes depending on the buyer pool.
- McLerran & Associates builds a CPA-led, sell-side-only valuation designed to hold up when buyers scrutinize it.
Get Your Practice Evaluated by McLerran & Associates
How to Calculate the Fair Market Value of Your Dental Practice
A defensible valuation follows a sequence: gather the source data, normalize earnings, then cross-check the result against three methods. The sections below walk through each stage in order.
- Gather three years of profit-and-loss statements, collections by provider, owner compensation and benefits, and active-patient counts.
- Normalize owner compensation and discretionary expenses to arrive at true EBITDA.
- Apply the collections-percentage method for a private-buyer benchmark.
- Apply the EBITDA-multiple method for a DSO benchmark.
- Cross-check with an asset-based floor, then pressure-test the number against a buyer’s offer before signing.
What to Gather Before You Calculate
A defensible valuation starts with complete, well-organized source data. Before running any formula, assemble the following:
- Three years of profit-and-loss statements and tax returns
- Collections by provider (separating owner production from associate production)
- All forms of owner compensation: W-2 wages, distributions, retirement contributions, and benefits
- Active-patient counts, defined consistently (typically patients seen within the trailing 18–24 months)
- Hygiene production as a percentage of total collections
- Equipment list with age and maintenance records
- Lease terms, renewal options, and remaining lease length
A three-year average can be more defensible than a single year because it smooths out one-time events and shows a trend. A declining revenue trend itself can be a valuation input. Buyers often treat it as a forward-looking forecast, not a historical footnote. Why numbers differ across years can be a key part of the story you present to a buyer.
Method 1: The Collections-Percentage Method (Private-Buyer Benchmark)
Fair market value ≈ average annual collections × the applicable percentage range.
The collections-percentage method is the most widely cited benchmark in doctor-to-doctor dental practice sales. The ADA states that dental practices typically sell for 65–85% of the average of the last three years of collections, and some sources place the range as wide as 60–95% depending on practice quality, overhead, payer mix, and hygiene production.
Applied to a practice with a three-year average of $1.2 million in collections, the same revenue produces a $240,000 spread depending on where in the range you land:
- At 60%: $720,000
- At 70%: $840,000
- At 80%: $960,000
That $240,000 spread on identical revenue highlights the method’s core limitation. It does not account for overhead at all. Two practices each collecting $1 million but running 55% versus 72% overhead would be valued identically by the rule despite a significant difference in actual owner earnings. The collections-percentage method can be a useful starting benchmark for doctor-to-doctor transactions. It shows where to begin the conversation, and other methods show where to end it. For a deeper look at how the market approach works, see how the market approach values a dental practice.
Method 2: The EBITDA-Multiple Method (DSO Benchmark)
Fair market value ≈ normalized EBITDA × the applicable multiple range.
Where Method 1 measures the practice against revenue, institutional buyers measure it against profit. DSOs and private equity-backed groups price on normalized EBITDA, not collections. They pay for normalized EBITDA, so two practices with identical collections can land at very different valuations depending on how much revenue falls to the bottom line. Normalization, the process of adjusting reported financials to reflect the practice’s true, ongoing earning power, becomes the most important calculation in the entire process.
The Normalization Walkthrough
This example uses the same $1.2 million-collections practice from Method 1. Assume the practice reports $180,000 in net income on its P&L.
Step 1: Build base EBITDA. Add back interest, taxes, depreciation, and amortization to net income. Assume $20,000 in interest, $40,000 in depreciation, and $15,000 in taxes. Base EBITDA equals $255,000.
Step 2: Normalize owner compensation, the largest single swing. The owner paid themselves $350,000 in total compensation. A market-rate replacement associate for a general dentist is commonly benchmarked at roughly 28–32% of the owner’s personal production. If the owner personally produced $900,000 of the $1.2 million in collections, a 30% replacement rate yields a market wage of $270,000. The add-back equals $350,000 paid minus $270,000 market rate, or $80,000 added back to EBITDA. This add-back is often the most contested item in a quality-of-earnings review, so production reports and local compensation benchmarks can be essential support.
Step 3: Add back personal and discretionary expenses.
- Personal auto expenses run through the practice: $12,000
- Personal travel and club dues: $8,000
- Family payroll above market rate (spouse paid $75,000 as office manager; market rate is $55,000): $20,000
- One-time equipment purchase expensed in a single year: $25,000
Total add-backs from personal and non-recurring items equal $65,000.
Running total: $255,000 (base EBITDA) + $80,000 (owner comp normalization) + $65,000 (personal/non-recurring) equals $400,000 normalized EBITDA.
That $145,000 difference between base EBITDA and normalized EBITDA carries real weight. At a 6x multiple, it represents $870,000 in enterprise value. The purpose of normalization is to help the financial statements more accurately reflect ongoing earning power.
What Moves The Multiple
Multiples are not fixed. A 2026 size-based framework reports typical ranges of 5–7x adjusted EBITDA for practices under $1 million in EBITDA, 7–9x for $1–3 million, 9–11x for $3–5 million, and 11x or more in select cases above $5 million. Several factors can move a practice within or between those tiers:
- Practice size and EBITDA scale: larger EBITDA can earn a higher multiple, not just a larger base.
- Number of providers: owner-concentrated production (90%+ from one doctor) can reduce value by an estimated 10–20%.
- Hygiene share of collections: practices where hygiene accounts for 30–35% of total production tend to perform better in valuation conversations.
- Payer mix: commercial and PPO revenue can support higher multiples, while heavy Medicaid concentration can compress the multiple.
- Specialty: oral and maxillofacial surgery can command premiums at the high end. General dentistry often earns aggressive valuations. Prosthodontics tends toward the lower end. These are general ranges only, and specialty-specific multiples can vary widely by deal.
- Revenue durability: a declining trend, high patient attrition, or a short remaining lease term all push toward the lower end of the range.
For a full explanation of how these methods compare, see dental practice valuation methods.
Method 3: The Asset-Based Method and Goodwill
Methods 1 and 2 both estimate value from earnings. The asset-based approach works from the other direction and values a practice as the fair market value of its tangible assets, such as chairs, equipment, technology, leasehold improvements, and supplies, plus the value of goodwill and the active-patient chart base. IRS Revenue Ruling 59-60, the foundational authority on valuing private companies, notes that for companies selling products or services, earnings may be the most important criterion of value. For a profitable going concern, the asset approach usually functions as a floor check rather than a primary method.
AICPA Statement on Standards for Valuation Services (SSVS) No. 1 requires the analyst to consider all three valuation approaches, income, market, and asset, for any formal valuation engagement. In practice, goodwill typically makes up the large majority of a going concern’s value. In a representative dental practice sale, roughly 80% of the price was attributable to goodwill. If the asset-based value lands close to the earnings-based value, that result can signal that EBITDA may be overstated or that normalization is incomplete.
The Same Practice Valued Two Ways: Private Buyer vs. DSO
This section carries the example practice through both methods side by side to show how buyer type can change the outcome.
For the $1.2 million-collections practice with $400,000 in normalized EBITDA:
- Private buyer (collections method): roughly $720,000–$960,000, paid mostly in cash at closing.
- DSO (EBITDA method): roughly $2,000,000–$2,800,000, with 25–40% of that often arriving as rollover equity or earnout.
A well-run doctor-to-doctor process with strong hygiene production and a clean patient base might land near the top of the private-buyer range. On the DSO side, even at the lower end of the range, the institutional number can be more than double the private-buyer number because the DSO prices the practice as a cash-flow asset, not as a percentage of revenue.
The gap is real, but the headline numbers are not directly comparable. Typical DSO deal structure in the $500K–$5M+ EBITDA range runs 60–75% cash at close, 15–30% rollover equity, and 5–15% earnout tied to retained EBITDA over 12–36 months. A private buyer typically pays 100% cash at closing with no earnout and only a short transition period. Once you account for that difference, a $1.2 million private sale paid in full at closing can outperform a $1.6 million DSO offer with a 35% earnout component after taxes, deferred payment risk, and post-sale obligations are factored in.
For smaller practices, roughly $1–1.5 million in collections, a private buyer typically pays close to 100% cash at closing while a DSO pays only about 60–80% up front with the rest in rollover equity or earnouts. Once deal structure is accounted for, the private-buyer offer can be competitive with or superior to a DSO offer. DSOs may still pay more, less, or nothing at all depending on size, margin, and market.
For dental practices with at least $1.5 million in annual collections and strong EBITDA margins, generally $250,000+ in EBITDA after doctor compensation, an IDSO partnership typically produces a higher total economic outcome than a traditional doctor-to-doctor sale, since IDSOs value practices on EBITDA multiples, often 7x–10x, rather than a percentage of collections. Not all practices qualify, and headline values may include earnouts or rolled equity rather than all cash at close. Because McLerran & Associates runs both paths in roughly equal measure, approximately 50/50, it can produce a true side-by-side valuation rather than steering owners toward one lane.
Why Your Number and the Buyer’s Number Will Differ and How to Defend It
Every add-back in a normalization schedule can be challenged. A buyer’s quality-of-earnings team, the accountants and analysts who review the financials after a letter of intent (LOI) is signed, will request 36 months of credit card statements, every W-2, production reports by provider, and documentation for every non-recurring expense claimed. A well-organized dental practice sale with clean financials and a prepared seller typically runs four to eight months from confidential marketing launch to closing, and documentation gaps consistently extend timelines and increase late-stage repricing.
A valuation built on undocumented add-backs rarely survives this process. The deal gets re-traded, meaning the buyer reduces the agreed price after the LOI, when the seller has already invested months of time and emotional energy and has limited leverage to walk away. The difference between a reactive sale and a prepared one can represent 1–2x turns of EBITDA, which on a $500,000 EBITDA practice equals $500K–$1M in value left on or off the table.
Free calculator estimates and napkin-math valuations produce a number with no documentation behind it. Because there is no line-by-line normalization or owner-compensation reset, there is nothing to show a buyer’s team when they scrutinize the add-backs. That gap is what turns a weakly supported valuation into the buyer’s negotiating tool instead of the seller’s anchor.
McLerran & Associates helps control the narrative around EBITDA from the first engagement. The CPA-led analysis unpacks every add-back before the practice goes to market, so the number is built to hold up rather than rebuilt under pressure after an LOI. The firm has also blacklisted poorly run buyers, so the competitive process it runs excludes counterparties known for re-trading deals or creating poor post-close environments.
Conclusion: Your Number, Calculated and Defended
A dental practice’s fair market value comes from a calculated, normalized, cross-checked number, not a rule of thumb. The collections-percentage method provides a private-buyer benchmark. The EBITDA-multiple method provides a DSO benchmark. The asset-based method provides a floor. All three are required by professional valuation standards, and none of them is complete without a thorough normalization of owner compensation and discretionary expenses.
The arithmetic matters, and so does who builds it. McLerran & Associates is a dental-specific valuation and sell-side advisory firm for calculating the fair market value of your dental practice because of its CPA-led, diligence-grade EBITDA analysis, 10,000+ practices evaluated, approximately 2,000 completed sales, roughly $2 billion in closed transaction volume, and sell-side-only advocacy. The valuation is built to hold up when buyers scrutinize it, and the deal is less likely to get re-traded after the LOI.
For more on what goes into a defensible valuation, see whether a free dental practice valuation is worth it and the full overview of dental practice valuation methods.
Schedule A Free Discovery Call
Frequently Asked Questions
What Is the Typical Rule of Thumb for Valuing a Dental Practice?
The most commonly cited rule of thumb today is 65%–85% of average annual collections over the prior three years, up from the 55%–75% range used in the 1980s and 1990s, per DDSmatch as cited by Scouly. Some sources place the range as wide as 60–95% depending on practice quality. This benchmark applies primarily to doctor-to-doctor sales and ignores overhead entirely, so two practices with identical collections but different profitability will produce very different actual values. It can be a useful sanity check, but a full valuation requires normalization and cross-checking with other methods.
How Much Should I Sell My Dental Practice For?
The right asking price depends on which buyer market you are targeting, your normalized EBITDA, and the specific factors that move your practice within its applicable multiple range, such as hygiene share, payer mix, provider concentration, lease terms, and revenue trend. A private buyer will typically price on collections or seller’s discretionary earnings, while a DSO will price on normalized EBITDA. The two numbers can differ substantially for the same practice, so a side-by-side valuation can be the clearest way to see which path serves you better.
Is It Hard to Sell a Dental Practice?
Selling without professional representation can be genuinely difficult. Do-it-yourself close rates can run as low as 15–20%, compared to roughly 80% for a well-run brokered process. The process involves financial documentation, buyer qualification, confidential marketing, negotiation, quality-of-earnings defense, and coordination across attorneys, lenders, and advisors, all while the practice continues to operate. Deals can fall apart at multiple points, and a valuation that cannot survive buyer scrutiny is one of the most common reasons they do.
What Is the 80/20 Rule in Dentistry?
In the context of practice valuation, the 80/20 concept most often refers to owner dependence. Buyers of dental practices view owner production concentration as a significant risk well before 80%. Glacier Lake Partners classifies a founding dentist producing 50–70% of collections as “significant concern” and more than 70% as “high concern,” and TUSK Practice Sales notes buyers price in key-provider risk when an owner produces 60–70% or more of revenue. If the selling doctor leaves and takes patient relationships with them, the cash flow the buyer underwrote may not materialize. This concentration can reduce a practice’s valuation multiple and can be one of the primary reasons buyers apply a discount or walk away when a single provider dominates production.
What Is Normalized Cash Flow in a Dental Practice Valuation?
Normalized cash flow, often expressed as normalized EBITDA, is what the practice earns after removing expenses that are personal, one-time, or specific to the current owner, and after resetting owner compensation to what it would cost to hire a replacement associate at market rates. It represents the practice’s true, ongoing earning power under new ownership. Common add-backs include personal vehicle expenses, family payroll above market rate, one-time equipment purchases, and the difference between what the owner paid themselves and what a market-rate associate would cost.
How Do DSO Valuations Differ from Private-Buyer Valuations?
Private buyers typically price on collections or seller’s discretionary earnings (SDE), which keeps the owner’s full compensation in the earnings figure. DSOs price on normalized EBITDA, which resets owner pay to a market replacement rate and produces a lower earnings base but a higher multiple. DSOs also often pay part of the price in rollover equity and earnouts, while private buyers usually pay all cash. The comparison section above models what that difference can mean in dollars.
What Should I Do Once I Have My Valuation Number?
A valuation number is the beginning of the process. The next steps are to understand which buyer market, private or DSO, produces the better outcome for your specific practice, to build a competitive process that creates multiple offers rather than negotiating with a single buyer, and to ensure every add-back in the normalization schedule is documented well enough to survive a buyer’s quality-of-earnings review. A number that cannot be defended in diligence functions more like an opening bid that a buyer’s team can trade down after the LOI is signed.
